logo
15:58 Jun 01

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
425.65
-3.00 (-0.70%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Biocon Ltd. Financials

Biocon Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
425.65
-3.00 (-0.70%)
15:58 Jun 01
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

56/100
Technically Neutral

Strength

6

Weakness

11

Opportunity

1

Threats

0

1.13 %

ROE %

0.60 %

ROA %

2.38

EPS

209.94

BVPS

2.27 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
8184 11174.2 14755.7 15261.7 16927
Operating Expenses +
6213.8 8662.5 11457 12095.4 13471.7
Raw Material
2975 3817.2 5754.6 4903.3 6640.2
Increase Decrease in Cost
-256.6 -154.1 -856.7 294.2 -949.5
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1880.1 2181 2664.1 3144.4 3508
Miscellaneous Expenses
1937.5 4070.6 5260.4 5006.7 6998.2
Operating Profit
1970.2 2511.7 3298.7 3166.3 3455.3
Other Income
212.7 375.9 865.5 1208.2 342.5
Depreciation
814.2 1113.1 1568.8 1687 1956.7
Interest
67.6 419 974.4 897.4 990.3
Profit before tax and exceptio..
1301.1 1355.5 1621 1790.1 850.8
Exceptional Items
-111.1 -291.4 -11.6 96.5 -402.9
PBT
1190 1064.1 1609.4 1886.6 447.9
Provision for Taxation
211.5 254.1 227.4 457.2 79.1
Net Profit
978.5 810 1382 1429.4 368.8
NET Profit after MI
648.4 462.7 1022.5 1013.3 385.6
EPS
5.42 3.88 8.55 8.46 2.82
Operating Profit Margin (%)
24.07 22.48 22.36 20.75 20.41
Net Profit Margin (%)
7.92 4.14 6.93 6.64 2.28

Biocon Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: